First fibrotic disease drug discovered in Singapore advances into Phase II clinical studies

This progress marks a significant translational milestone with the potential to impact a devastating disease with limited treatment options.

Duke-NUS News Hub

Ageing, smoking, oral bacteria and genetic mutations linked to higher stomach cancer risk

Read more

Duke-NUS scientists uncover how exercise helps ageing muscles repair themselves

Read more

Duke and Duke-NUS’ joint cross-population research to uncover "East-West" differences in disease and care

Read More

Seniors in Singapore visit the dentist less often, are at risk of growing more frail: Study

Read More

New tool reveals hidden metabolic weakness in blood cancers: Duke-NUS study

Read More

Derita tersembunyi wanita Melayu sebagai penjaga terhimpit antara dua generasi

Read More

Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool

Read More

Commentary: What obesity and palliative care reveal about the economies of health and healthcare

Read More

Innovation with purpose, powered by people

Browse the first print edition of MEDICUS 

Learn more

Media releases

18 Nov 2025
Advancing industry–academia alliance to nurture the next generation of innovative MedTech talents
17 Nov 2025
Duke-NUS study: Over 90% of older adults with dementia undergo burdensome interventions in their final year
13 Nov 2025
Collaborations key to unlocking the potential of AI in transforming medical education: Duke-NUS study

Commentaries

14 Oct 2025
Commentary: AI in healthcare a game changer for Singapore, if we get the rules right first
27 Sep 2025
Commentary: Ageing well begins in the neighbourhood, but doesn’t end there
09 Sep 2025
Commentary: Beyond dengue: The mosquito-borne virus that could be our next big outbreak

Our stories

2025: A year in review

PhDs, pivots and possibilities: rethinking career paths at the 17th DUNES Symposium

Duke-NUS and SingHealth researchers among the world’s most influential scientists

What the media say...

09 Nov 2025

Opinion: #StrongNotSkinny: Why I want chunky legs

The Straits Times
07 Nov 2025

Singapore scientists build detailed map of developing human brain

CNA
17 Oct 2025

SPNS1 mutations reveal new lysosomal lipid recycling pathway

Drug Target Review

Publications

Duke-NUS brand

Discover the story of Duke-NUS, a beacon of graduate medical education and research excellence in Singapore that combines tradition with innovation. Our brand, too, is much more than a series of words or a logo. It embodies who we are and what we stand for. We are leveraging our diverse experiences, skillsets and perspectives to address challenges in medicine, and create impact that improves the lives of patients in Singapore and beyond.

Browser not supported

Modern websites need modern browsers

To enjoy the full experience, please upgrade your browser

Try this browser